| [1] |
LU KQ, SUI JJ, YU WH, et al. An analysis of the burden of liver cirrhosis: Differences between the global, China, the United States and India[J]. Liver Int, 2024, 44( 12): 3183- 3203. DOI: 10.1111/liv.16087.
|
| [2] |
DEVARBHAVI H, ASRANI SK, ARAB JP, et al. Global burden of liver disease: 2023 update[J]. J Hepatol, 2023, 79( 2): 516- 537. DOI: 10.1016/j.jhep.2023.03.017.
|
| [3] |
KARLSEN TH, SHERON N, ZELBER-SAGI S, et al. The EASL-Lancet Liver Commission: Protecting the next generation of Europeans against liver disease complications and premature mortality[J]. Lancet, 2022, 399( 10319): 61- 116. DOI: 10.1016/S0140-6736(21)01701-3.
|
| [4] |
KRONSTEN VT, SHAWCROSS DL. Clinical implications of inflammation in patients with cirrhosis[J]. Am J Gastroenterol, 2025, 120( 1): 65- 74. DOI: 10.14309/ajg.0000000000003056.
|
| [5] |
HARTL L, SIMBRUNNER B, JACHS M, et al. Lower free triiodothyronine(fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality[J]. JHEP Rep, 2023, 6( 1): 100954. DOI: 10.1016/j.jhepr.2023.100954.
|
| [6] |
JALAN R, D'AMICO G, TREBICKA J, et al. New clinical and pathophysiological perspectives defining the trajectory of cirrhosis[J]. J Hepatol, 2021, 75( Suppl 1): S14- S26. DOI: 10.1016/j.jhep.2021.01.018.
|
| [7] |
LEE SS, YOO YC. NOX-NOS crosstalk in the liver-brain axis: Novel insights for redox regulation and neurodegenerative diseases[J]. Redox Biol, 2025, 86: 103807. DOI: 10.1016/j.redox.2025.103807.
|
| [8] |
KRONSTEN VT, TRANAH TH, PARIANTE C, et al. Gut-derived systemic inflammation as a driver of depression in chronic liver disease[J]. J Hepatol, 2022, 76( 3): 665- 680. DOI: 10.1016/j.jhep.2021.11.008.
|
| [9] |
SHAHEEN AA, KAPLAN GG, SHARKEY KA, et al. Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study[J]. Liver Int, 2021, 41( 10): 2308- 2317. DOI: 10.1111/liv.14973.
|
| [10] |
MARJOT T, RAY DW, WILLIAMS FR, et al. Sleep and liver disease: A bidirectional relationship[J]. Lancet Gastroenterol Hepatol, 2021, 6( 10): 850- 863. DOI: 10.1016/S2468-1253(21)00169-2.
|
| [11] |
ZIMBREAN PC, JAKAB SS. Depression and anxiety management in cirrhosis[J]. Hepatol Commun, 2024, 9( 1): e0600. DOI: 10.1097/HC9.0000000000000600.
|
| [12] |
KIM M, LIOTTA EM, MAAS MB, et al. Rest-activity rhythm disturbance in liver cirrhosis and association with cognitive impairment[J]. Sleep, 2021, 44( 6): zsaa288. DOI: 10.1093/sleep/zsaa288.
|
| [13] |
ZHAO YH, HU YS, SMITH JP, et al. Cohort profile: The China health and retirement longitudinal study(CHARLS)[J]. Int J Epidemiol, 2014, 43( 1): 61- 68. DOI: 10.1093/ije/dys203.
|
| [14] |
LARSEN A, PINTYE J, ODHIAMBO B, et al. Comparing depression screening tools(CESD-10, EPDS, PHQ-9, and PHQ-2) for diagnostic performance and epidemiologic associations among postpartum Kenyan women: Implications for research and practice[J]. J Affect Disord, 2023, 324: 637- 644. DOI: 10.1016/j.jad.2022.12.101.
|
| [15] |
TANG L, YIN RY, HU Q, et al. The effect of childhood socioeconomic status on depressive symptoms in middle-old age: The mediating role of life satisfaction[J]. BMC Psychiatry, 2022, 22( 1): 398. DOI: 10.1186/s12888-022-04046-3.
|
| [16] |
KROENKE K, SPITZER RL, WILLIAMS JB. The PHQ-9: Validity of a brief depression severity measure[J]. J Gen Intern Med, 2001, 16( 9): 606- 613. DOI: 10.1046/j.1525-1497.2001.016009606.x.
|
| [17] |
COOPER KM, COLLETTA A, OSORIO B, et al. History of depression is associated with higher prevalence of hepatic encephalopathy in patients with advanced liver disease[J]. Am J Med, 2024, 137( 9): 872- 879. e 2. DOI: 10.1016/j.amjmed.2024.04.036.
|
| [18] |
WUNSCH E, KRAUSE L, GEVERS TJ, et al. Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE-LIVER online survey[J]. Liver Int, 2023, 43( 2): 381- 392. DOI: 10.1111/liv.15440.
|
| [19] |
ALRABADI LS, DUTTON A, RABIEE A, et al. Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis[J]. JHEP Rep, 2022, 4( 5): 100450. DOI: 10.1016/j.jhepr.2022.100450.
|
| [20] |
FENG Q, IZZI-ENGBEAYA CN, MANOUSOU P, et al. Obesity drives the link between liver fat and depression: Cross-sectional and prospective investigations[J]. Diabetes Obes Metab, 2025, 27( 9): 5127- 5134. DOI: 10.1111/dom.16562.
|
| [21] |
ÅSTRÖM H, SHANG Y, HAGSTRÖM H, et al. Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression[J]. Liver Int, 2024, 44( 10): 2551- 2563. DOI: 10.1111/liv.16019.
|
| [22] |
KARDASHIAN A, SERPER M, TERRAULT N, et al. Health disparities in chronic liver disease[J]. Hepatology, 2023, 77( 4): 1382- 1403. DOI: 10.1002/hep.32743.
|
| [23] |
LEDENKO M, PATEL T. Poverty traps and mortality from liver diseases in the United States[J]. Am J Gastroenterol, 2024, 119( 12): 2462- 2470. DOI: 10.14309/ajg.0000000000002899.
|